Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity

International Journal of Obesity

Volumn 40, Issue 2, 2016, Pages 275-280

  Kelly, A S ^a   Ryder, J R ^a,b   Marlatt, K L ^a,c   Rudser, K D ^b   Jenkins, T ^d   Inge, T H ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR;

ADOLESCENT; ARTICLE; BARIATRIC SURGERY; CONTROLLED STUDY; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; INFLAMMATION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SLEEP DISORDERED BREATHING; SLEEVE GASTRECTOMY; ATHEROSCLEROSIS; BLOOD; COMPLICATION; GASTRIC BYPASS SURGERY; INSULIN RESISTANCE; OBESITY, MORBID; PATHOPHYSIOLOGY; PEDIATRIC OBESITY; POSTOPERATIVE PERIOD; TIME FACTOR; UNITED STATES; WEIGHT REDUCTION;

ADIPOKINES; ADIPONECTIN; ADOLESCENT; ATHEROSCLEROSIS; BIOMARKERS; FEMALE; GASTRIC BYPASS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LIPOPROTEINS, LDL; MALE; OBESITY, MORBID; OXIDATIVE STRESS; PEDIATRIC OBESITY; POSTOPERATIVE PERIOD; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES; WEIGHT LOSS;

EID: 84957842546     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.174     Document Type: Article

References (41)

1. Kelly AS, Metzig AM, Schwarzenberg SJ, Norris AL, Fox CK, Steinberger J. Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity. Metab Syndr Relat Disord 2012; 10: 123-127.
2. Norris AL, Steinberger J, Steffen LM, Metzig AM, Schwarzenberg SJ, Kelly AS. Circulating oxidized LDL and inflammation in extreme pediatric obesity. Obesity (Silver Spring) 2011; 19: 1415-1419.
3. Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol 2006; 26: 2541-2546.
4. Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation 2013; 128: 1689-1712.
5. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
6. Alqahtani AR, Antonisamy B, Alamri H, Elahmedi M, Zimmerman VA. Laparoscopic sleeve gastrectomy in 108 obese children and adolescents aged 5 to 21 years. Ann Surg 2012; 256: 266-273.
7. Inge TH, Jenkins TM, Zeller M, Dolan L, Daniels SR, Garcia VF et al. Baseline BMI is a strong predictor of Nadir BMI after adolescent gastric bypass. J Pediatr 2010; 156: 103-108.
8. O'Brien PE, Sawyer SM, Laurie C, Brown WA, Skinner S, Veit F et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA 2010; 303: 519-526.
9. Auguet T, Terra X, Hernandez M, Sabench F, Porras JA, Orellana-Gavalda JM et al. Clinical and adipocytokine changes after bariatric surgery in morbidly obese women. Obesity (Silver Spring) 2014; 22: 188-194.
10. Hakeam HA, O'Regan PJ, Salem AM, Bamehriz FY, Jomaa LF. Inhibition of C-reactive protein in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg 2009; 19: 456-460.
11. Illan-Gomez F, Gonzalvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragon-Alonso A, Pascual-Diaz M et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 2012; 22: 950-955.
12. Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis 2011; 7: 618-624.
13. Rao SR. Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res 2012; 61: 789-807.
14. Ruiz-Tovar J, Oller I, Galindo I, Llavero C, Arroyo A, Calero A et al. Change in levels of C-reactive protein (CRP) and serum cortisol in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg 2013; 23: 764-769.
15. Uzun H, Zengin K, Taskin M, Aydin S, Simsek G, Dariyerli N. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 2004; 14: 659-665.
16. Butte NF, Brandt ML, Wong WW, Liu Y, Mehta NR, Wilson TA et al. Energetic adaptations persist after bariatric surgery in severely obese adolescents. Obesity (Silver Spring) 2015; 23: 591-601.
17. Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL et al. Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation 2011; 123: 2749-2769.
18. Inge TH, Zeller M, Harmon C, Helmrath M, Bean J, Modi A et al. Teen-Longitudinal Assessment of Bariatric Surgery: methodological features of the first prospective multicenter study of adolescent bariatric surgery. J Pediatr Surg 2007; 42: 1969-1971.
19. Miyano G, Jenkins TM, Xanthakos SA, Garcia VF, Inge TH. Perioperative outcome of laparoscopic Roux-en-Y gastric bypass: a children's hospital experience. J Pediatr Surg 2013; 48: 2092-2098.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
21. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351: 2599-2610.
22. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
23. Bertoni AG, Burke GL, Owusu JA, Carnethon MR, Vaidya D, Barr RG et al. Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2010; 33: 804-810.
24. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53: 693-700.
25. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844-848.
26. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M. Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb 1993; 13: 331-337.
27. Kelly AS, Jacobs DR Jr, Sinaiko AR, Moran A, Steffen LM, Steinberger J. Relation of circulating oxidized LDL to obesity and insulin resistance in children. Pediatr Diabetes 2010; 11: 552-555.
28. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004; 27: 547-552.
29. Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005; 111: 747-753.
30. Verges B, Petit JM, Duvillard L, Dautin G, Florentin E, Galland F et al. Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol 2006; 26: 1364-1369.
31. Terra X, Auguet T, Guiu-Jurado E, Berlanga A, Orellana-Gavalda JM, Hernandez M et al. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg 2013; 23: 1790-1798.
32. Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R, Marras V et al. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab 2008; 93: 3051-3057.
33. Gallistl S, Sudi KM, Aigner R, Borkenstein M. Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program. Int J Obes Relat Metab Disord 2001; 25: 1640-1643.
34. Murer SB, Knopfli BH, Aeberli I, Jung A, Wildhaber J, Wildhaber-Brooks J et al. Baseline leptin and leptin reduction predict improvements in metabolic variables and long-term fat loss in obese children and adolescents: a prospective study of an inpatient weight-loss program. Am J Clin Nutr 2011; 93: 695-702.
35. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004; 89: 3790-3794.
36. Roberts CK, Izadpanah A, Angadi SS, Barnard RJ. Effects of an intensive short-term diet and exercise intervention: comparison between normal-weight and obese children. Am J Physiol Regul Integr Comp Physiol 2013; 305: R552-R557.
37. Roth CL, Kratz M, Ralston MM, Reinehr T. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism 2011; 60: 445-452.
38. Ryder JR, Vega-Lopez S, Gaesser GA, Buman MP, Shaibi GQ. Heterogeneous vascular responses to lifestyle intervention in obese Latino adolescents. Metab Syndr Relat Disord 2014; 12: 509-515.
39. Kelly AS, Steinberger J, Olson TP, Dengel DR. In the absence of weight loss, exercise training does not improve adipokines or oxidative stress in overweight children. Metabolism 2007; 56: 1005-1009.
40. Balagopal P, George D, Patton N, Yarandi H, Roberts WL, Bayne E et al. Lifestyleonly intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 2005; 146: 342-348.
41. Danielsson P, Kowalski J, Ekblom O, Marcus C. Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med 2012; 166: 1103-1108.